AC133, a novel marker for human hematopoietic stem and progenitor cells.

Abstract:

:AC133 is one of a new panel of murine hybridoma lines producing monoclonal IgG antibodies (mAbs) to a novel stem cell glycoprotein antigen with a molecular weight of 120 kD. AC133 antigen is selectively expressed on CD34(bright) hematopoietic stem and progenitor cells (progenitors) derived from human fetal liver and bone marrow, and blood. It is not detectable on other blood cells, cultured human umbilical vein endothelial cells (HUVECs), fibroblast cell lines, or the myeloid leukemia cell line KG1a by standard flow cytometric procedures. All of the noncommitted CD34(+) cell population, as well as the majority of CD34(+) cells committed to the granulocytic/monocytic pathway, are stained with AC133 antibody. In vitro clonogenicity assays have demonstrated that the CD34(+)AC133(+) double-positive population from adult bone marrow contains the majority of the CFU-GM, a proportion of the CFU-Mix, and a minor population of BFU-E. The CD34(dim) and AC133(-) population has been shown to contain the remaining progenitor cells. AC133-selected cells engraft successfully in a fetal sheep transplantation model, and human cells harvested from chimeric fetal sheep bone marrow have been shown to successfully engraft secondary recipients, providing evidence for the long-term repopulating potential of AC133(+) cells. A cDNA coding for AC133 antigen has been isolated, which codes for a polypeptide consisting of 865 amino acids (aa) with a predicted size of 97 kD. This antigen is modeled as a 5-transmembrane molecule, a structure that is novel among known cell surface structures. AC133 antibody provides an alternative to CD34 for the selection and characterization of cells necessary for both short- and long-term engraftment, in transplant situations, for studies of ex vivo expansion strategies, and for gene therapy.

journal_name

Blood

journal_title

Blood

authors

Yin AH,Miraglia S,Zanjani ED,Almeida-Porada G,Ogawa M,Leary AG,Olweus J,Kearney J,Buck DW

subject

Has Abstract

pub_date

1997-12-15 00:00:00

pages

5002-12

issue

12

eissn

0006-4971

issn

1528-0020

journal_volume

90

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Erratum: Airoldi I, Bertaina A, Prigione I, et al. γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes. Blood. 2015;125(15):2349-2358.

    abstract::[This corrects the article DOI: 10.1182/blood-2014-09-599423.]. ...

    journal_title:Blood

    pub_type: 杂志文章,已发布勘误

    doi:10.1182/blood-2016-02-700625

    authors:

    更新日期:2016-03-24 00:00:00

  • Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.

    abstract::Ectopic expression of fibroblast growth factor receptor 3 (FGFR3) associated with t(4;14) has been implicated in the pathogenesis of human multiple myeloma. Some t(4;14) patients have activating mutations of FGFR3, of which a minority are K650E (thanatophoric dysplasia type II [TDII]). To investigate the role of autop...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-09-3686

    authors: Chen J,Williams IR,Lee BH,Duclos N,Huntly BJ,Donoghue DJ,Gilliland DG

    更新日期:2005-07-01 00:00:00

  • The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes.

    abstract::We have used (cryo) electron tomography to provide a 3-dimensional (3D) map of the intracellular membrane organization of human platelets at high spatial resolution. Our study shows that the open canalicular system and dense tubular system are highly intertwined and form close associations in specialized membrane regi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-268680

    authors: van Nispen tot Pannerden H,de Haas F,Geerts W,Posthuma G,van Dijk S,Heijnen HF

    更新日期:2010-08-19 00:00:00

  • T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency.

    abstract::In common variable immunodeficiency (CVID) defects in early stages of B-cell development, bone marrow (BM) plasma cells and T lymphocytes have not been studied systematically. Here we report the first morphologic and flow cytometric study of B- and T-cell populations in CVID BM biopsies and aspirates. Whereas the hema...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-321695

    authors: Ochtrop ML,Goldacker S,May AM,Rizzi M,Draeger R,Hauschke D,Stehfest C,Warnatz K,Goebel H,Technau-Ihling K,Werner M,Salzer U,Eibel H,Schlesier M,Peter HH

    更新日期:2011-07-14 00:00:00

  • Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage.

    abstract::The cytokine interleukin-10 (IL-10) has been implicated in the pathogenesis of a number of disease states, including Epstein-Barr virus and human immunodeficiency virus (HIV-1) infections. In the acquired immunodeficiency syndrome (AIDS), it has been suggested that IL-10 may have a deleterious effect by suppressing ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Saville MW,Taga K,Foli A,Broder S,Tosato G,Yarchoan R

    更新日期:1994-06-15 00:00:00

  • Viral infection triggers rapid differentiation of human blood monocytes into dendritic cells.

    abstract::Surprisingly little is known about the interaction of human blood mononuclear cells with viruses. Here, we show that monocytes are the predominant cell type infected when peripheral blood mononuclear cells are exposed to viruses ex vivo. Remarkably, infection with vesicular stomatitis virus, vaccinia virus, and a vari...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-09-379479

    authors: Hou W,Gibbs JS,Lu X,Brooke CB,Roy D,Modlin RL,Bennink JR,Yewdell JW

    更新日期:2012-03-29 00:00:00

  • FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin.

    abstract::The role of fibroblast growth factors (FGFs) in blood vessel formation has remained unclear. We used differentiating stem-cell cultures (embryoid bodies) and teratomas to show that FGF receptor-1 (FGFR-1) exerts a negative regulatory effect on endothelial cell function in these models. Embryoid bodies lacking expressi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-067314

    authors: Magnusson PU,Dimberg A,Mellberg S,Lukinius A,Claesson-Welsh L

    更新日期:2007-12-15 00:00:00

  • Modulation of the folate receptor type beta gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites.

    abstract::Folate receptor (FR) type beta is a promising target for therapeutic intervention in acute myelogenous leukemia (AML) owing particularly to its specific up-regulation in AML cells by all-trans retinoic acid (ATRA). Here we identify functional elements in the FR-beta gene and examine the molecular mechanism of transcri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-10-3174

    authors: Hao H,Qi H,Ratnam M

    更新日期:2003-06-01 00:00:00

  • Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement.

    abstract::Sixty-five patients with hairy cell leukemia underwent splenectomy; 27 had a complete remission as defined by a return in WBC, RBC, and platelet counts to a defined level, and 38 had a partial remission with a return of only one or two of these parameters to the defined level. The 5-yr actuarial survival for all patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Golomb HM,Vardiman JW

    更新日期:1983-02-01 00:00:00

  • Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

    abstract::Chemotherapy-related myeloid neoplasia (t-MN) is a significant late toxicity concern after cancer therapy. In the randomized intergroup phase 3 E2997 trial, initial therapy of chronic lymphocytic leukemia with fludarabine plus cyclophosphamide (FC) compared with fludarabine alone yielded higher complete and overall re...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-03-342485

    authors: Smith MR,Neuberg D,Flinn IW,Grever MR,Lazarus HM,Rowe JM,Dewald G,Bennett JM,Paietta EM,Byrd JC,Hussein MA,Appelbaum FR,Larson RA,Litzow MR,Tallman MS

    更新日期:2011-09-29 00:00:00

  • Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.

    abstract::We have used monoclonal antibodies (M Abs) and proteolytic fragmentation to localize structurally the functional sites of human von Willebrand factor (vWF) responsible for interaction with membrane glycoproteins GPIb, GPIIb/IIIa, and with collagen. SpII (215 kd) and SpIII (320 kd), the S aureus V-8 protease homodimeri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Girma JP,Kalafatis M,Piétu G,Lavergne JM,Chopek MW,Edgington TS,Meyer D

    更新日期:1986-05-01 00:00:00

  • Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations.

    abstract::We describe in vitro studies and a therapeutic trial of retinoic acid (RA) in a patient with acute promyelocytic leukemia (APL) refractory to chemotherapy. Bone marrow promyelocytes from the patient, prior to RA, matured morphologically in liquid culture with RA (97% maturing myeloid cells compared with 26% in control...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Flynn PJ,Miller WJ,Weisdorf DJ,Arthur DC,Brunning R,Branda RF

    更新日期:1983-12-01 00:00:00

  • The clinical applications of genome editing in HIV.

    abstract::HIV/AIDS has long been at the forefront of the development of gene- and cell-based therapies. Although conventional gene therapy approaches typically involve the addition of anti-HIV genes to cells using semirandomly integrating viral vectors, newer genome editing technologies based on engineered nucleases are now all...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-01-678144

    authors: Wang CX,Cannon PM

    更新日期:2016-05-26 00:00:00

  • Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann-Pick disease patients.

    abstract::Types A and B Niemann-Pick disease (NPD) result from the deficient activity of acid sphingomyelinase (ASM; E.C. 3.1.4.12) and the resultant lysosomal accumulation of sphingomyelin. Type A disease is a fatal, neurodegenerative disorder of infancy, whereas type B disease has no neurologic manifestations and is character...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Levran O,Desnick RJ,Schuchman EH

    更新日期:1992-10-15 00:00:00

  • Characterization of influenza A virus activation of the human neutrophil.

    abstract::Neutrophil dysfunction consequent to influenza A virus infection has been described in vivo and in vitro and may contribute to the serious bacterial sequelae which occur in influenza-infected hosts. On the premise that such dysfunction may represent a form of "deactivation," we sought to characterize neutrophil activa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hartshorn KL,Collamer M,White MR,Schwartz JH,Tauber AI

    更新日期:1990-01-01 00:00:00

  • Antilymphocytic antibodies and marrow transplantation. XII. Suppression of graft-versus-host disease by T-cell-modulating and depleting antimouse CD3 antibody is most effective when preinjected in the marrow recipient.

    abstract::A hamster antimouse CD3 monoclonal antibody (MoAb) opened the way to experimental studies on the suppression of allograft rejection and cytokine-related morbidity after treatment with antibodies modulating the CD3/T-cell receptor complex (CD3/TCR). Because earlier attempts to suppress graft-versus-host disease (GVHD) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mysliwietz J,Thierfelder S

    更新日期:1992-11-15 00:00:00

  • Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism.

    abstract::Deficiency of folate or vitamin B(12) (cobalamin) causes megaloblastic anemia, a disease characterized by pancytopenia due to the excessive apoptosis of hematopoietic progenitor cells. Clinical and experimental studies of megaloblastic anemia have demonstrated an impairment of DNA synthesis and repair in hematopoietic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Koury MJ,Price JO,Hicks GG

    更新日期:2000-11-01 00:00:00

  • Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor.

    abstract::Acute myeloid leukemia (AML) is an aggressive malignancy with a relapse rate approaching 50%, despite aggressive chemotherapy. New therapies for AML are targeted at signal transduction pathways known to support blast survival, such as the Stat3 pathway. Aberrant activation of Stat3 has been demonstrated in many differ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-280123

    authors: Redell MS,Ruiz MJ,Alonzo TA,Gerbing RB,Tweardy DJ

    更新日期:2011-05-26 00:00:00

  • Tyrosine kinase and phosphotyrosine phosphatase activity in human promyelocytic leukemia cells and human polymorphonuclear leukocytes.

    abstract::Although an increase in protein phosphorylation on tyrosine was first noted as a result of cell transformation or the application of growth factors to cells, recent reports have shown high levels of tyrosine kinases in nondividing tissues. For that reason, we have investigated whether normal human polymorphonuclear le...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kraft AS,Berkow RL

    更新日期:1987-08-01 00:00:00

  • Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation.

    abstract::The tal-1 gene encodes a basic helix-loop-helix (bHLH) transcription factor required for primitive and definitive hematopoiesis. Additionally, ectopic activation of the tal-1 gene during T lymphopoiesis occurs in numerous cases of human T-cell acute lymphoblastic leukemia. With the use of transgenic mice, we show that...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.2.491

    authors: Goardon N,Schuh A,Hajar I,Ma X,Jouault H,Dzierzak E,Roméo PH,Maouche-Chrétien L

    更新日期:2002-07-15 00:00:00

  • Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study Group.

    abstract::Transfusions purportedly induce dysfunction of cell-mediated immunity in sickle cell anemia (SCA). We studied hematologic and lymphocytic indices in 173 human immunodeficiency virus (HIV)-negative subjects with SCA and 131 black controls. Children aged 1 to 7 years with SCA had leukocyte counts and percentages of gran...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Wong WY,Powars DR,Operskalski EA,Hassett J,Parker JW,Sarnaik S,Pegelow CH,Hilgartner MW,Johnson CS,Zhou Y

    更新日期:1995-04-15 00:00:00

  • Large granular lymphocytes in human peripheral blood: ultrastructural and cytochemical characterization of the granules.

    abstract::Large granular lymphocytes (LGL) are defined as nonadherent mononuclear cells with cytoplasmic azurophilic granules, avid receptors for the Fc portion of IgG, and cytotoxic functions (NK or ADCC activities). In the present study, the granules of LGL isolated from human peripheral blood have been analyzed by enzyme cyt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Grossi CE,Cadoni A,Zicca A,Leprini A,Ferrarini M

    更新日期:1982-02-01 00:00:00

  • Hydroxyurea in the management of the hematologic complications of chronic granulocytic leukemia.

    abstract::The effect of hydroxyurea in 35 patients with chronic granulocytic leukemia (CGL), who either had entered an accelerated phase of the disease or had experienced excessive myelosuppression following alkylating agents, was studied. By either intravenous or oral administration, the drug was successful in reducing periphe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schwartz JH,Cannellos GP

    更新日期:1975-07-01 00:00:00

  • PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.

    abstract::The heterodimeric transcription factor RUNX1/PEBP2-beta (also known as AML1/CBF-beta) is essential for definitive hematopoiesis. Here, we show that interaction with PEBP2-beta leads to the phosphorylation of RUNX1, which in turn induces p300 phosphorylation. This is mediated by homeodomain interacting kinase 2 (HIPK2)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-134122

    authors: Wee HJ,Voon DC,Bae SC,Ito Y

    更新日期:2008-11-01 00:00:00

  • Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis.

    abstract::The transcription factor TAL1 has major functions during embryonic hematopoiesis and in adult erythropoiesis and megakaryocytopoiesis. These functions rely on different TAL1 structural domains that are responsible for dimerization, transactivation, and DNA binding. Previous work, most often done in mice, has shown tha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1689

    authors: Ravet E,Reynaud D,Titeux M,Izac B,Fichelson S,Roméo PH,Dubart-Kupperschmitt A,Pflumio F

    更新日期:2004-05-01 00:00:00

  • Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine.

    abstract::Chronic lymphocytic leukemia (CLL) is characterized by delayed senescence and slow accumulation of monoclonal, small lymphocytes. Basic fibroblast growth factor (bFGF) is a pleiotropic cytokine that plays a role in hematopoiesis and apoptosis. Elevated bFGF levels have been detected in urine from patients with a varie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Menzel T,Rahman Z,Calleja E,White K,Wilson EL,Wieder R,Gabrilove J

    更新日期:1996-02-01 00:00:00

  • Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.

    abstract::Dickkopf-1 (DKK1), a soluble inhibitor of Wnt signaling secreted by multiple myeloma (MM) cells contributes to osteolytic bone disease by inhibiting the differentiation of osteoblasts. In this study, we tested the effect of anti-DKK1 therapy on bone metabolism and tumor growth in a SCID-rab system. SCID-rab mice were ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-047712

    authors: Yaccoby S,Ling W,Zhan F,Walker R,Barlogie B,Shaughnessy JD Jr

    更新日期:2007-03-01 00:00:00

  • Localization of thrombospondin in clots formed in situ.

    abstract::Thrombospondin is a principal glycoprotein secreted by thrombin-stimulated platelets and has known affinities for fibrinogen and fibrin. We studied the distribution of thrombospondin in clots formed in situ on Formvar-coated coverslips at 37 degrees C for intervals up to 17 hours. The distributions of three other majo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Murphy-Ullrich JE,Mosher DF

    更新日期:1985-11-01 00:00:00

  • Production and nucleotide sequence of an inhibitory human IgM autoantibody directed against platelet glycoprotein Ia/IIa.

    abstract::Human B-cell lines were derived by limiting dilutions of Epstein-Barr virus (EBV) transformed peripheral B cells from a patient with an autoantibody against glycoprotein (GP)Ia/IIa, and manifesting defective collagen-induced platelet aggregation and a bleeding problem. Antibody-producing clones were selected for their...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Deckmyn H,Zhang J,Van Houtte E,Vermylen J

    更新日期:1994-09-15 00:00:00

  • Erythropoiesis-inhibiting factor(s) (EIF): methodologic studies.

    abstract::Erythropoiesis-inhibiting factors (EIF) have been demonstrated in plasma from hypertransfused animals and from polycythemic individuals during periods of hyperoxia, but there is a decided discrepancy in the data published. In the present paper methodologic variations of a bioassay for demonstrating the erythropoiesis-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lindemann R

    更新日期:1976-01-01 00:00:00